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BACKGROUND: Lymphatic filariasis (LF) is a neglected tropical 
disease (NTD) vectored by mosquito; and people in rural areas are 
mostly at risk of infection. Pooling prevalence data across the six 
geo-political zones of Nigeria is expected to provide a clearer 
insight into the burden of the disease as this information could 
guide towards planning eradication programmes. 
METHODS: Search for pertinent literature was done on Google 
Scholar, African Journal Online (AJOL) and PubMed databases 
using relevant keywords.  Studies on the prevalence of LF due to 
Wuchereria bancrofti in Nigeria were selected and reviewed. 
Prevalence data from the different states were further organized 
into the six geopolitical zones and analyzed. 
RESULTS: Of the 36 states in Nigeria, prevalence data were 
available only for 19 states. Furthermore, in the six geopolitical 
zones, North-West had the highest disease burden (44 per 10 000) 
of Years Lived with Disability (YLD), while North-Central (4 per 10 
000) had the lowest disease burden. 
CONCLUSION: Result are largely attributed to the prevailing 
conditions in the different zones.  In view of ensuring a successful 
control plan and eventual eradication of the disease, a 
comprehensive national survey in every state should be carried out 
using more sensitive tools. 





Wuchereria bancrofti vectored by mosquitoes is a human parasitic 
filarial round worm responsible for the disease-lymphatic filariasis 
(LF) (1). Of note, is the fact that Wucheriria bancrofti is more 
prevalent than filariasis from Brugia malayi and Brugia timori ,as 
infection could advance to a chronic stage like elephantiasis of the 
extremities and genitals (1).  
In sub-Saharan Africa, 512 million people are at risk of being 
infected, while 28 million are known to be infected (2). Although 
mortality from LF is low, the disease is the fourth leading cause of 
Disability Adjusted Life Years (DALYs) (2,3). 
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Nigeria is ranked the third most endemic country 
globally; and in the past, studies on the disease 
distribution were classified based on the disease 
prevalence at national or sub-national levels with 
no account for geopolitical zones heterogeneity (4). 
Therefore, such estimates did not accurately 
capture LF burden at zonal levels (5).  Analyzing 
data at geopolitical/zonal level would provide more 
detailed report on the dynamics of the disease in a 
way that the disease prevalence and burden could 
be mapped and as such guide on control strategy. 
This review article thus presents prevalence data of 
LF from endemic areas in Nigeria and highlights 




LF, after malaria happens to be the second most 
common vector-borne parasitic diseases; and it is 
present in over 80 tropical and subtropical 
countries (6). According to WHO, LF ranks second 
as the common cause of long-term disability after 
mental illness (6,7). LF is of global recognition, 
playing a significant role in the overall Africa 
disease burden. Furthermore, one-third of infected 
persons live in India, a third live in Africa and the 
remainder in the Americas, the Pacific Island, 
Papua New Guinea and South-East Asia (8). 
Persons with LF and other helminthic diseases 
particularly women and children become more 
susceptible to secondary infection with HIV/AIDS, 
tuberculosis and malaria (2). LF is known to cause 
a wide range of clinical and subclinical symptoms. 
It is estimated that two-thirds of infected 
individuals present no obvious proof of the disease, 
but when tested, they showed some level of 
immunosuppression. In addition, there could be 
evidence of renal dysfunction, chronic 
lymphoedema, elephantiasis and hydrocele.  
Evidence of debilitating effect of acute filarial 
attacks that have been said to last from five to 
seven days and may occur two to three times each 
year have been associated with sufferers of LF 
(6,7). Chronic filarial disease appears to correlate 
with serious social and economic burden as those 
afflicted with elephantiasis and hydrocele are often 
socially marginalized and are poor based on the 
severity of disease (9). Episodes of acute attack and 
chronic disability reduce economic output and 
increase poverty (6). Due to stigmatization, 
affected individuals avoid seeking treatment, and 
this result in the reoccurrence of acute febrile 
attacks and subsequent damage to the lymphatic 
system (9,10). Infected women bear double burden 
as young unmarried women could be forced to live 
a secluded life and thus limit the prospect of 
marriage. 
More so, recurrent debilitating acute episodes 
hinder their ability to be gainfully employed. 
Consequently, the cost of health care as well as 
other needs make them financially dependent on 
other people (11,12). In West Africa and Thailand, 
there is a general believe that children born to 
women affected by LF would bear similar disease 
burden (2,13).  Shame and fear are associated with 
difficulties in conceiving, and these feelings are 
peculiar to LF patients globally (14). Meanwhile, 
women may have concerns about marrying men 
with physical sign of LF; their gender expectation 
and prevailing power strata often leave them in 
hopeless situations. In Haiti and Ghana, researchers 
alluded to the point that the risk of unhappiness and 
marriage breakdown was greater in marriages 
where the wife had physical signs of filariasis 
(11,15).  
 In Nigeria, LF is widespread and it is a 
serious public health problem (1). Of the 36 states, 
LF studies were available for nineteen states (19) 
(Table 1). These studies spanned through the 
different geo-political zones (North-West, North-
East, North-Central, South-West, South-East and 
South-South) of the country., However, there is 
still limited/lack of literature on the prevalence of 
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Table 1. Prevalence of Lymphatic filariasis across Zones and State. 
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DEC: diethylcarbamazine; ICT: immunochromatographic test; RDT: Rapid diagnostic test. 
 
Cases of high prevalence of LF due to Wuchereria 
bancrofti have been reported with infection rates 
ranging between 9.1% and 18.8% in the eastern 
region and northern region respectively (16). Mbah 
and Njoku (17) reported a prevalence rate of 18.8% 
in Anambra State. Udonosi (18) observed 
prevalence rates of 8.7%, 11.8% and 14.9-25.6% in 
Imo and Rivers States respectively. Co-endemicity  
of Wuchereria bancrofti, Loa loa, Onchercerca 
volvulus with Mansonella perstans had a 
prevalence rate of 21.21% in Rivers and Bayelsa 
States (18). Furthermore, Braide et al (19) reported 
13 cases of LF in Cross Rivers State. Amadi and 
Udonosi (20) also reported a prevalence rate of 
4.4% in Ogoniland, Rivers State. Recently, Dogara 
et al (21a) reported a prevalence rate of 30.2% in 
Kano. More recently, Ladan et al (22) in his studies 
on the seroprevalence of LF in six communities of 
Bungudu Local Government Area of Zamfara State 
reported a prevalence rate of 38.72%. The 
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prevalence data in North-East, North-West and South-West is largely unknown (Figure 1). 
Figure 1: Prevalence data for Wucheriria bancrofti in the six geopolitical zones of Nigeria. 
 
LF has impacted negatively on marriage and sexual 
life in endemic areas. Stigmatization of men with 
hydrocoele is also observed in some of the endemic 
countries as villagers in some parts of Nigeria 
discontinues association from people with filarial 
skin lesions and men with genital complications 
and elephantiasis (3). Furthermore, of the 128 
million people estimated to be infected worldwide 
(11,23,24), 22 million (17.2%) are children 
(school-aged) below the age of 15. LF ranks the 
second leading cause of long-term disability (7). 
More so, it has been linked with serious 
impairment of mobility (25), affecting school-aged 
children’s education and future career prospects 
due to regular absenteeism from school (26). The 
affected children become frustrated to the point 
that they abandon their education and future 
endeavors (27).  
Poor response of victims to submit themselves 
for examination and refusal to give night blood 
samples are challenges against the effective study 
of LF in Nigeria (20). Environmental factors and 
conditions influencing LF transmission are similar 
to those existing elsewhere in the tropics and other 
sub-Saharan African countries. Factors such as 
rural to urban migration, increasing urbanization, 
inadequate waste disposal and deteriorating 
sanitary conditions in the country could increase 
the number of breeding sites for the mosquito 
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dipterans in transmitting the parasitic agents of 
filariasis are poorly acknowledged in many 
endemic communities. Therefore, it is surprising 
that there is little awareness on the need to 
minimize mosquito contact. Vectors like Culex 
papiens quinquefasciatus are distributed across the 
tropics and warm temperate regions and are 
believed to be indigenous to the low lands of West 
Africa. These vectors have reached the new world 
through slave ships; meanwhile an alternate 
hypothesis suggest it originates in Southeast Asia 
(29). Culex papiens quinquefasciatus are found in 
association with other mosquitoes’ species in 
domestic and peri domestic water containers (30).  
Breeding takes place in eutrophic water of artificial 
containers or man-made impoundments like 
ditches, ponds, drains with high nutrient containing 
human or animal sewage (30). Factors such as 
adequate rainfall and longevity of the female C.p. 
quinquefasciastus have been attributed to survival 
and reproduction. With distinct rainy season, their 
population reaches its peak densities during or 
immediately after the rainy season, while in 
subtropical and warm temperate areas, peak 
populations occur during the warmest month of the 
year (30).  Stomoxys species is a filth fly with 
worldwide medical and veterinary importance. 
There are 18 known species in the genus Stomoxys. 
Stomoxys calcitran is the only species that is 
synanthropic and present worldwide. Stomoxys 
species breeds in moist, decaying organic matter, 
while suitable environmental conditions like 
temperature of 270C, availability of host for blood 
meal, influence their survival and reproduction 
(31). Some of these associated agents that 
contribute to spread of the disease increase the 
disease burden, and hence, impacting positively on 
the spread of the disease. 
There are many diagnostic methods available 
for the detection of LF. Until the 1980s, the only 
direct method to ascertain a diagnosis of infection 
by W. bancrofti was via the identification of 
microfilariae (MF) in the peripheral blood using 
camera counting, polycarbonate membrane 
filtration, the thick smear method or Knott’s 
technique (32). Meanwhile, apart from their 
relatively low sensitivities, these methods only 
identify filarial infection by way of microfilaremia. 
In the 1990s, significant improvements were 
made in the diagnosis of LF with the emergence of 
new diagnostic tools; namely, use of recombinant 
antigens to detect specific antibodies (33), PCR for 
the detection of filarial DNA, the visualization of 
live adult worms (AW) using ultrasound (US) and 
circulating filarial antigen (CFA) detection (34). 
Presently, the standard diagnostic tools are US (34) 
and CFA detection technique, with the latter using 
the monoclonal antibodies (McAbs) Og4C3 and 
AD12. Meanwhile, the CFA detection techniques 
are commercially available in the form of kits with 
the advantage of ensuring the possibility of 
diagnosis using blood samples collected at any 
time of the day (34,35). However, in Nigeria, there 
is no report of the use of molecular diagnostic tools 
for LF infection; therefore, we believe that the 
prevalence estimates presented in this report is 




In drafting a cost-effective control for diseases, it is 
paramount that the disease burden be estimated. 
Disability Adjusted Life Year (DALYs) has 
become fast increasing metric measurement to 
assess disease burden (36). DALYs include years 
of life lost due to mortality (YLLs) and years lived 
with disability (YLDs). Reports of LF infection 
burden measured in DALYs are unavailable. Here, 
we have estimated the value of YLD (Table 2) 
based on the available prevalence data and 
morbidity of the infection (37). YLD due to LF in 
this review was estimated using this formula (38): 
YLD = P × DW; Where P = number of prevalence 
cases, DW=Disability Weight. 
Furthermore, prevalence was used rather than 
incidence (38), because in Nigeria, surveys are 
widely reported in prevalence (Table 1). However, 
DW (0.027) of infection which is represented on a 
scale of 0-1 (0=perfect health; 1=death), was 
adopted (39). YLDs due to LF, according to the 
geo-political zones are shown in Table 2. This 
review shows that the YLD from LF prevalence 
data in Nigeria ranged from 4.0 to 44.0 with the 
highest and least disease burdens recorded in 
North-West and North-Central respectively.  
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Table 2. Lymphatic filariasis mean prevalence and estimated YLD according to geopolitical zones (1982-
2018).  
 
Region  Mean ± SD (%)  YLD per 10 000         
North-West 9.4 ± 14.5                                            44.0 
North-East                                      23.5 ± 13.3                                            16.0
North-Central                                  9.6 ± 15.4                                              4.0
South-West 17.9 ± 11.3                                            16.0
South-East                                                                                   16.6 ± 6.6 17.0 
South-South 7.4 ± 4.7   10.0 
 
Control and elimination rely largely on 
chemotherapy through mass drug administration 
(MDA) to interrupt transmission of infection (40). 
Drugs commonly administered against LF in 
Nigeria are diethylcarbamazine (DEC), 
Albendazole and ivermectin. Studies based on 
selective treatment with single dose of DEC 
(6mg/kg) have been reported to decrease MF by 
90% and adult by 50% (40). Furthermore, vector 
control methods such as the use of insecticides 
treated mosquito nets, indoor residual spraying as 
well as environmental sanitation would reduce the 
vector population and consequently the 
transmission of the disease. The YLD data in this 
report has clearly described the national situation 
and thus call for the need to intensify surveillance 
and treatment across all strata. LF control in 
Nigeria should especially be of high priority in the 
North-West.  
The data in this review have highlighted LF 
prevalence in Nigeria, with North-West having the 
highest disease burden. The high prevalence in the 
North-West is largely attributed to unfavorable 
climatic conditions that threw up man-made 
options like construction of irrigation, thereby 
further enhancing the disease vectors to thrive. It is 
recommended that LF survey be carried out in 
states where prevalence data are yet to be available, 
so that a proper and more comprehensive 
evaluation of the LF situation in Nigeria be done to 
the extent that the most effective control strategy 
can be adopted and applied. Furthermore, to have a 
near-accurate picture of the prevalence of the 
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